← Back to Search

Behavioural Intervention

ABM-01 for Social Anxiety Disorder

N/A
Waitlist Available
Led By Tracy A Dennis-Tiwary, PhD
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up bi-weekly time point and at the 6 and 12 month follow-ups

Summary

This trial tests a mobile app called ABM-01 to help adults aged 22-65 with Social Anxiety Disorder. Participants use the app regularly for a period to manage and reduce their social anxiety symptoms.

Eligible Conditions
  • Social Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~bi-weekly time point and at the 6 and 12 month follow-ups
This trial's timeline: 3 weeks for screening, Varies for treatment, and bi-weekly time point and at the 6 and 12 month follow-ups for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Anxiety
Depression, Anxiety, and Stress Scale (DASS-21)
Generalized Anxiety Disorder - 7 (GAD-7)
+4 more
Other study objectives
Anxiety Sensitivity Index (ASI-3)
Beck Depression Inventory II (BDI-II)
Patient Health Questionnaire (PHQ-2)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental groupExperimental Treatment1 Intervention
Participants receive active ABM-01 for the study
Group II: Placebo ControlPlacebo Group1 Intervention
Participants receive a digital control for the study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ABM-01
2022
N/A
~150

Find a Location

Who is running the clinical trial?

Wise Therapeutics Inc.UNKNOWN
Hunter College of City University of New YorkLead Sponsor
40 Previous Clinical Trials
8,764 Total Patients Enrolled
Arcade Therapeutics Inc.UNKNOWN
~44 spots leftby Nov 2025